2024-01-01 2024-12-31 false No description of principal activity Capium Accounts Production 1.1 07890935 2024-01-01 2024-12-31 07890935 bus:FullAccounts 2024-01-01 2024-12-31 07890935 bus:Micro-entities 2024-01-01 2024-12-31 07890935 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07890935 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07890935 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07890935 2024-01-01 2024-12-31 07890935 2024-12-31 07890935 bus:RegisteredOffice 2024-01-01 2024-12-31 07890935 core:WithinOneYear 2024-12-31 07890935 core:AfterOneYear 2024-12-31 07890935 1 2024-01-01 2024-12-31 07890935 bus:Director1 2024-01-01 2024-12-31 07890935 bus:Director1 2024-12-31 07890935 bus:Director1 2023-01-01 2023-12-31 07890935 2023-01-01 07890935 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 07890935 2023-01-01 2023-12-31 07890935 2023-12-31 07890935 core:WithinOneYear 2023-12-31 07890935 core:AfterOneYear 2023-12-31 07890935 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 07890935 core:PlantMachinery 2024-01-01 2024-12-31 07890935 core:PlantMachinery 2024-12-31 07890935 core:PlantMachinery 2023-12-31 07890935 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 07890935 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 07890935 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 07890935 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 07890935 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 07890935 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 07890935 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 07890935 core:Non-currentFinancialInstruments 2024-12-31 07890935 core:Non-currentFinancialInstruments 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07890935
England and Wales

 

 

 

ZIGMA MEDICAL LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
Director Vishal SAHNI
Registered Number 07890935
Registered Office Flat 3, Advertiser Court
2 Telegraph Avenue
London
NW9 4BL
Accountants A1 Accountax
Gilbert Wakefield House
67 Bewsey Street
Warrington
WA2 7JQ
1
  2024   2023
    £ £   £ £
(as restated)
Fixed assets   212,263      212,263 
Current assets 36,892      124,503   
Creditors: amount falling due within one year (127,058)     (52,879)  
Net current assets   (90,166)     71,624 
Total assets less current liabilities   122,097      283,887 
Creditors: amount falling due after more than one year   (24,131)     (65,280)
Net assets   97,966      218,607 
 

         
Capital and reserves   97,966      218,607 
 
NOTES TO THE ACCOUNTS

General Information
ZIGMA MEDICAL LTD is a private company, limited by shares, registered in England and Wales, registration number 07890935, registration address Flat 3, Advertiser Court, 2 Telegraph Avenue, London, NW9 4BL.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).

3.

Prior Period Adjustment – Restatement of Comparative Figures

During the prior year ended 31 December 2023, the company incorrectly applied a revaluation to an investment property, which is not permitted under FRS 105. A revaluation adjustment of £116,125 was recorded, reducing the carrying value of the fixed asset and creating a corresponding revaluation reserve in equity. The journal entry posted was:

Credit Fixed Asset Investment: £116,125
Debit Revaluation Reserve: £116,125


This treatment was not compliant with FRS 105, which requires investment properties to be measured at cost less depreciation and impairment, and does not allow for revaluation.

In the current year, this error has been corrected by reversing the above journal entry and restating the comparative figures. As a result:

  • The carrying value of fixed assets as at 31 December 2023 has been restated from £96,137 to £212,262.
  • Capital and reserves (equity) as at 31 December 2023 have been restated from £102,482 to £218,607.
This correction has no impact on the reported profit or loss for the year ended 31 December 2023 but has resulted in an adjustment to the balance sheet comparatives.

For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 14 July 2025 and were signed by:


--------------------------------
Vishal SAHNI
Director
2